Abacavir drug sulfate, identified by the chemical designation 188062-50-2, represents a crucial agent reverse polymerase utilized in the therapy of HIV infections. Its molecular weight is approximately 359.36 g/mol, exhibiting a crystalline structure and a moderate solubility. The principal ingredient functions by inhibiting the viral enzyme, there